Inotiv (NOTVQ) EBIT Margin (2010 - 2026)
Inotiv's (NOTVQ) quarterly EBIT Margin came in at 16.41% in Q1 2026, down 1405.0% YoY from 1.26% in Q1 2025, and down 21.49% on a QoQ basis from 13.51% in Q4 2025.
Inotiv (NOTVQ) EBIT Margin (2010 - 2026) Analysis & Trends
Inotiv (NOTVQ) has 17 years of EBIT Margin data on file, last reported at 16.41% in Q1 2026.
- Quarterly EBIT Margin fell 1405.0% year-over-year to 16.41% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.48% (up 142.0% YoY) and the FY2025 annual result came in at 6.02%, up 1158.0% from the prior year.
- EBIT Margin slipped to 16.41% in Q1 2026, from 13.51% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 5.61% in Q1 2022 to a low of 161.14% in Q3 2022.
- A 5-year average of 20.47% and a median of 6.92% in 2023 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2022 — EBIT Margin tumbled 14981 bps — and 2023, when it soared 16289 bps.
- Tracing NOTVQ's EBIT Margin over 5 years: stood at 73.79% in 2022, then jumped by 91 bps to 6.92% in 2023, then slumped by 87 bps to 12.94% in 2024, then decreased by 4 bps to 13.51% in 2025, then slipped by 21 bps to 16.41% in 2026.
- The last three EBIT Margin figures came in at 16.41% (Q1 2026), 13.51% (Q4 2025), and 4.91% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn | -16.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.41% |
| Dec 31, 2025 | -13.51% |
| Sep 30, 2025 | -4.91% |
| Jun 30, 2025 | -4.34% |
| Mar 31, 2025 | -2.36% |
| Dec 31, 2024 | -12.94% |
| Sep 30, 2024 | -10.10% |
| Jun 30, 2024 | -19.62% |
| Mar 31, 2024 | -36.22% |
| Dec 31, 2023 | -6.92% |
| Sep 30, 2023 | 1.75% |
| Jun 30, 2023 | 5.58% |
| Mar 31, 2023 | -1.40% |
| Dec 31, 2022 | -73.79% |
| Sep 30, 2022 | -161.14% |
| Jun 30, 2022 | 2.77% |
| Mar 31, 2022 | 5.61% |
| Dec 31, 2021 | -39.95% |
| Sep 30, 2021 | -11.33% |
| Jun 30, 2021 | -7.44% |